BUD-EXCHANGE

[sam1933]

GREEN-FIELDS
http://www.green-fields.org/perfect-stock-trades--good-favor-team.html
A GOOD FAVOR COMMUNITY
HERE TO PLAY A MAJOR ROLE IN SAVING OUR WORLD
FOR OUR CHILDREN
-----------------------------------------------------------
PICKS BY, BIRDYS3333 follow me at http://investorshub.advfn.com/boards/profilea.aspx?user=422953

HEMP The legalization of the cannabis and hemp industries are becoming more of a reality each day. One by one, states are legalizing cannabis for medical and recreational uses. Alongside marijuana legalization is hemp cultivation, the strongest natural fiber known to man with applications ranging from food, nutrition, body care, paper, fabric, textiles, rope, fuel, plastic alternatives, building materials, medicine, and so much more..023 a/o 4/09/15--> .019 a/o 4/20/15,-->.021 a/o 4/27/15-->.0199 a/o 5/03/15-->.0195 a/o 5/11/15

CBIS The mainstream pharmaceutical industry is capital-intensive and constrained by high regulatory hurdles, making the profitability of any particular product a long-term prospect. Cannabis Science™ is different in three key respects:
The Company will, at least in its first phase of existence, deal primarily in intellectual properties "patents on products and processes" leaving capital-intensive problems such as regulatory compliance, mass production and marketing to the "old guard" pharmaceutical companies who license our patents.
We will focus on a relatively new and under-explored niche in the pharmaceutical market: Whole-plant cannabinoid compounds derived from certified organic ingredients. The existing pharmaceutical industry is heavily geared, by inclination and in terms of infrastructure, toward the development and testing of synthetic compounds.
Cannabis Science™ has strong roots in, and an established relationship of trust with, the US and Canadian medical cannabis patient communities. In the course of product and process development, we'll do "well" by doing "good" - our products will receive baseline efficacy testing in that community. Since medical cannabis already inherently exceeds all reasonable standards of safety, potential licensees will approach the regulatory process with a reasonable expectation that the products and processes they license will easily exceed that process's safety and efficacy standards. Thus our products and processes will enjoy a significant advantage over previously untested synthetics.037 as of 4/09/15 -->.036 a/o 4/20/15,-->.0395 a/o 4/27/15-->.033 a/o 5/03/15-->.03 a/o 5/11/15

UNGS Formed in July 2014, Bud Bank, LLC is dedicated solely to the Company's new automated cannabis dispensing product. Through the licensing agreement entered into between The Greater Cannabis Company, LLC and Artemis Dispensing Technologies, a new automated cannabis dispensing product is currently in development. This new product, marketed under the name of Bud Bank, is scheduled to be completed during the fourth quarter of 2014. Further information on the Bud Bank dispensing kiosk can be found at www.greatercannabiscompany.com

along with vending machines, ungs also buy property for devolpement .0002 a/o 4/09/15-->,01 a/o 4/20/15,-->.0001 a/o 4/27/15-->.0002 a/o 5/03/15-->.0002 a/o 5/11/15

BABL, A Unique Shopping Platform
Buildablock is an online shopping platform that revolutionizes conventional online shopping. We bring together great ideas, such as group discounts, wish lists, online negotiations, and more into a unique venue that empowers shoppers to save on the items they want from the merchants they choose.
The company owns intellectual property rights comprising an Internet and mobile service platform whose purpose is to empower or capitalize on the growth of the neighborhood, local economy. In addition to its social networking library, the service includes its new ‘DealWink’ engine, a new e-commerce platform that combines the power of group buying, couponing, and price aggregation to drive both value to its customers and opportunity to the retailer..0029/ as of 4/09/15,--> .0026 a/o 4/20/15,-->.0026 a/o 4/27/15,-->.046 a/o 5/03/15-->.004 a/o 5/11/15

MJNA, has many products for mj market, edibles, candy, and much more! .091 as of 4/09/15-->.088 a/o 4/20/15,-->.08 a/o 4/27/15-->.079 a/o 5/03/15-->.061 a/o 5/11/15

THCZ , is another hemp company, with many good products, like beverages, and much more! .155 as of 4/09/15-->.26 a/o 4/20/15,-->.2099 a/o 4/27/15,-->.21 a/o 5/03/15-->.25 a/o 5/11/15

AMZZ , is a green company, currently working on automobiles that run on hydrogen! .0009 as of 4/09/15-->.0006 a/o 4/09/15,-->.0005 a/o 4/27/15,

TUNG, is a mining company, that mines rare minerals, like tungsten .0009 as of 4/09/15-->.0008 a/o 4/20/15,-->.0009 a/o 4/27/15-->.0008 a/o 5/03/15-->.0007 a/o 5/11/15

PICKS BY, Burn Notice 88 follow this expert at http://investorshub.advfn.com/boards/profilea.aspx?user=309890

RIGH, BG Medical develops Internet technology and biotechnology, focusing on medical cannabis, cannabis commerce, and natural health care solutions. Its products collect data through a network of proprietary software, utilized by patients, retail operators, and medical professionals. The Company's current flagship product, BudGenius.com, is a social web platform designed to assist cannabis patients in selecting regionally available medicine paired to their needs. . 0002 a/o 4/09/15-->.0002 a/o 4/20/15,-->.0002 a/o 4/27/15-->.0002 a/o 5/03/15-->.0001 a/o 5/11/15

The Company operates an analytical chemistry laboratory designed for natural medicine study, which is utilized to determine potency and safety guidance for patients and medicine manufacturers. Data collected from the laboratory is combined with patient feedback to produce information that benefits retail operators and informs patients on best available treatment options.
BudGenius.com maintains the most comprehensive online public database for scientifically tested cannabis worldwide.
CEO Angel Stanz blog: http://angelstanz.com/
Company Official Website: http://bgmedtech.com/
Bud Genius laboratory: http://budgenius.com/
What’s Due in 2015: http://bit.ly/1I5d0c9
Bud Genius, Inc. - Financial Facts: http://bit.ly/19MgynC .

PICKS BY OCKHAM'S RAZOR, follow this expert at http://investorshub.advfn.com/boards/profilea.aspx?user=303317
CYPW, Cyclone Power Technologies is the developer of the award-winning Cyclone Engine an all-fuel, clean-tech engine with the power and versatility to run everything from waste energy electric generators and solar thermal systems to cars, trucks and locomotives. Invented by company founder and Chairman Harry Schoell, the patented Cyclone Engine is an eco-friendly external combustion engine, ingeniously designed to achieve high thermal efficiencies through a compact heat-regenerative process, and to run on virtually any fuel -- including bio-diesels, syngas or solar -- while emitting fewer greenhouse gases and irritating pollutants into the air. The Cyclone Engine was recognized by Popular Science Magazine as the Invention of the Year for 2008, and was presented with two Society of Automotive Engineers' AEI Tech Awards. Additionally, Cyclone was named Environmental Business of the Year by the Broward County (Florida) Environmental Protection Department. For more information, visit www.cyclonepower.com. .0006 a/o 4/20/15,-->.0008 a/o 4/27/15-->.0006 a/o 5/03/15-->.0005 a/o 5/11/15

TCEL,The Company’s business operations consist of doing business in the cell repair and cell replacement for Equine stock
only at present, but we are pursuing FDA approval for existing and modified products to be used for the repair of the
Human Body. It is estimated that this process will take up to six months assuming a problem-free time-line and funds
available to complete. Its products have been successfully utilised for the repair of horses tendons and have the
added bonus of being patented worldwide, with an exclusive licence in the name of the Company for equine and
human applications. In October 2013 we had to cease trialing the process due to lack of available and sustainable
funds. The new initiative to generate investment into the company will allow us to recommence these trials and move
towards selling the equine product on the open market. As a result, the Company is still in development and approval
stage.
Whilst we have raised the previosly estimated $2million required to obtain US Food and Drug Administration approval
of the patented process for humans and to make the product available to our targeted markets our due diligence has
been completed and we are close to finalising the funding. The new loan investment in the Company would allow
trials to recommence. The delay in receiving the new funding has prevented us from pursuing the FDA approval,
appointing our preferred investor relations and public relations consultants and commissioning the new website.
We have also released into the market substantial amounts of Common stock that had previously been tied up in
convertible loan notes. Further increases in the authorized Common Stocks are not deemed necessary at present. .0003 a/o 4/20/15,-->.0007 a/o 4/27/15-->.0004 a/o 5/03/15-->.0005 a/o 5/03/15-->.0005 a/o 5/11/15
LPPI,.0048 a/o 5/03/15-->.0386 a/o 5/11/15

PICKS BY RICH DUDE, follow this expert at http://investorshub.advfn.com/boards/profilea.aspx?user=444773
AMPE, Ampio Pharmaceuticals, Inc. discovers and develops drugs for metabolic, eye, kidney, inflammation, and central nervous system diseases. The company's principal products include Optina, an oral drug that is in Phase II clinical trials for the treatment of diabetic retinopathy and macular edema; and Vasaloc, an oral drug in Phase II clinical trials for the treatment of diabetic nephropathy. It is also developing DMI-9523, a new molecular entity being developed as a non-steroidal oral drug for the treatment of diseases involving inflammation. Ampio Pharmaceuticals, Inc. was formerly known as DMI Life Sciences, Inc. and changed its name to Ampio Pharmaceuticals, Inc. in March 2010. Ampio Pharmaceuticals, Inc. was founded in 1990 and is based in Greenwood Village, Colorado. 2.51 a/o 5/03/15-->2.40 a/o 5/11/15

PRAN, Prana Biotechnology Limited, a development stage company, through its subsidiaries, engages in the research and development of therapeutic drugs in Australia. It offers PBT-2, which is in Phase II a clinical trial, for patients with Alzheimer?s disease. The company?s products are designed to treat the underlying causes of degeneration of brain and eye as the aging process progresses. The company primarily focuses on Alzheimer?s disease. Prana Biotechnology Limited was incorporated in 1997 and is based in Parkville, Australia.
1.195 a/o 5/03/15--> 1.22 a/o 5/11/15

CRDC
cardica's C-Port(R) Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed-Chest Heart Bypass Surgeries Wednesday September 5, 8:00 am ET - World's First Closed-Chest Procedures with Cardica's C-Port Flex A System Recently Conducted - REDWOOD CITY, Calif., Sept. 5 /PRNewswire-FirstCall/ -- Cardica, Inc. (Nasdaq: CRDC - News) today announced that two independent groups of leading cardiothoracic surgeons performed ground-breaking minimally-invasive, closed-chest bypass procedures using Cardica's C-Port Flex A Anastomosis System and Intuitive Surgical's da Vinci robot. The C-Port Flex A system, a fully-automated, flexible shaft device, automates the attachment, or anastomosis, of a blood vessel graft to a coronary artery during bypass surgery. (Photo: http://www.newscom.com/cgi-bin/prnh/20070905/AQW040 )
.4293 a/o 5/03/15-->.39 a/o 5/11/15